28 October 2009
EDGE™ Safety Hypodermic Syringes for Government flu preparedness effort
Smiths Medical today announces a contract award from the U.S. Department of Health and Human Services (HHS) for safety hypodermic syringes that could reach $10 million as part of the Government's national flu pandemic preparedness efforts.
Stuart Morris-Hipkins, president of Smiths Medical North America, said: "Expert estimates suggest that the H1N1 flu could affect half of all Americans, including groups like healthy young adults previously thought to be at low risk. We are proud to support the government's efforts to protect as many people as possible from H1N1 flu."
In addition to supplying important safety products, Smiths Medical staff will be available should an emergency need arise for additional products. The company, part of the global technology business Smiths Group, has also set aside dedicated warehouse space for HHS to help ensure that products are available whenever needed.
General media enquiries
Contact our global media and communications team at:
Please note – the press team can only answer enquiries from accredited members of the press.
Related articles
Smiths announces global, all employee share award as part of 175 year celebrations
Read our latest company news Smiths announces global, all employee share award as part of 175 year celebrations.
Find out more
Annual Results for the year ended 31 July 2026
Find out more
Smiths appoints new independent Non-executive Directors
Read our latest company news as the Board of Smiths is pleased to announce the appointments of Val Rahmani and Emma FitzGerald as independent Non-executive Directors.
Find out more
